Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preclinical safety profile of plasma prepared using the INTERCEPT Blood System.

Vox sanguinis - 1 Oct 2003

Ciaravino V, McCullough T, Cimino G, Sullivan T

Abstract excerpt

BACKGROUND AND OBJECTIVES: The newly developed INTERCEPT Blood System for plasma uses the addition of a new psoralen, amotosalen HCl (AMOTOSALEN), followed by illumination with ultraviolet A light, to inactivate viruses, bacteria, protozoa and leucocytes that may contaminate fresh-frozen plasma (FFP). Extensive toxicology studies were performed to characterize the safety of the photochemical treatment process for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Specimen Collection
Share to Donor Selection
Share to Photochemistry

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Photosensitizing Agents

Share to Plasma

Share to Safety

Share to Transfusion Reaction

Share to Vasculitis

Source

Identifiers

PMID: 14516447
DOI: 10.1046/j.1423-0410.2003.00351.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preclinical safety profile of plasma prepared using the INTERCEPT Blood System.PMID 14516447Read ↗

Cytotoxic and mutagenic potential of solutions exposed to cold atmospheric plasmaSemantic proximity Read ↗

A Nonclinical Safety Evaluation of Cold Atmospheric Plasma for Medical Applications: The Role of Genotoxicity and Mutagenicity StudiesSemantic proximity Read ↗

Chemical and Biological Mechanisms of Pathogen Reduction TechnologiesSemantic proximity Read ↗

Assessment of biosafety and toxicity of hydrophilic gel for implantation in experimental in vitro and in vivo modelsSemantic proximity Read ↗

Biomolecular Consequences of Platelet Pathogen Inactivation MethodsSemantic proximity Read ↗

Killing adherent and nonadherent cancer cells with the plasma pencilSemantic proximity Read ↗

Chemical Modulators of Fibrinogen Production and Their Impact on Venous Thrombosis.Semantic proximity Read ↗

Chemotherapy and delivery systems: haemoparasitesSemantic proximity Read ↗

NON-TOXIC ACID-FREE GLYOXAL FIXATIVE FOR VETERINARY HISTOPATHOLOGY, IMMUNOHISTOCHEMISTRY AND MOLECULAR ANALYSISSemantic proximity Read ↗

On the dose of plasma medicine: Plasma-activated medium (PAM) and its effect on cell viabilitySemantic proximity Read ↗

Quantitative Suspension Test for the Evaluation of a Cold Sterilization System Based on Reducing Free Radicals Compared to Autoclave Sterilization CyclesSemantic proximity Read ↗

The Effect of Plasma Activated Medium and PBS on Human Melanoma Cells Compared With Other Cancer and Normal CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.